Commerzbank Aktiengesellschaft FI Purchases 1,679 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Commerzbank Aktiengesellschaft FI raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 21.1% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 9,646 shares of the medical equipment provider’s stock after acquiring an additional 1,679 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in Intuitive Surgical were worth $5,035,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of the company. Howard Capital Management Group LLC grew its position in Intuitive Surgical by 4.5% in the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after purchasing an additional 92 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in shares of Intuitive Surgical by 35.1% during the 3rd quarter. Farther Finance Advisors LLC now owns 2,900 shares of the medical equipment provider’s stock worth $1,425,000 after buying an additional 754 shares during the last quarter. Chicago Partners Investment Group LLC grew its holdings in shares of Intuitive Surgical by 1.4% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 2,461 shares of the medical equipment provider’s stock valued at $1,261,000 after acquiring an additional 33 shares in the last quarter. Clear Creek Financial Management LLC increased its position in shares of Intuitive Surgical by 4.4% in the third quarter. Clear Creek Financial Management LLC now owns 1,551 shares of the medical equipment provider’s stock valued at $762,000 after acquiring an additional 66 shares during the last quarter. Finally, Optas LLC raised its holdings in Intuitive Surgical by 13.4% during the third quarter. Optas LLC now owns 651 shares of the medical equipment provider’s stock worth $320,000 after acquiring an additional 77 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on ISRG. CICC Research initiated coverage on Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Piper Sandler reiterated an “overweight” rating and issued a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. JPMorgan Chase & Co. boosted their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Finally, Bernstein Bank upped their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Stock Down 1.1 %

NASDAQ ISRG opened at $566.98 on Tuesday. The firm has a 50-day moving average price of $570.66 and a two-hundred day moving average price of $530.08. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The company has a market capitalization of $201.95 billion, a P/E ratio of 88.45, a P/E/G ratio of 5.85 and a beta of 1.39.

Insider Activity

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at $208,181.75. This trade represents a 53.61 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 12,598 shares of company stock worth $7,223,467. Corporate insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.